What is the treatment for Bodily Distress Disorder (BDD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Bodily Distress Disorder

Cognitive Behavioral Therapy (CBT) is the first-line treatment for Bodily Distress Disorder (BDD), with Selective Serotonin Reuptake Inhibitors (SSRIs) recommended as the primary pharmacological intervention when needed. 1

Psychological Interventions

Cognitive Behavioral Therapy

CBT has demonstrated significant efficacy in treating BDD with robust evidence supporting its use:

  • Structure and Format:

    • Typically requires 12-22 weekly sessions 1
    • More severe cases may need extended treatment (up to 80 sessions in some cases) 1
    • Treatment follows three main phases:
      1. Psychoeducation and formulation (sessions 1-3)
      2. Exposure with response prevention/behavioral experiments (from session 4)
      3. Relapse prevention (final sessions) 1
  • Key Components:

    • Exposure with Response Prevention (ERP) - core therapeutic technique
    • Behavioral experiments to test negative beliefs
    • Motivational interviewing techniques to enhance engagement
    • Psychoeducation about the nature of bodily distress 1
  • Efficacy:

    • Large effect sizes (Cohen's d = 1.13-1.22) in reducing symptoms 1
    • Improvements in secondary outcomes including depression, insight, and quality of life 1
    • Naturalistic studies show 79% response rates and 59% remission rates 1

Pharmacological Interventions

Selective Serotonin Reuptake Inhibitors (SSRIs)

  • First-line medication when pharmacotherapy is indicated 2, 3
  • Often used in conjunction with CBT (72% of patients in the largest naturalistic study received SSRIs alongside CBT) 1
  • Higher doses may be required for optimal response in severe cases 1

Other Medication Options

  • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs) may be considered as alternatives 4
  • Tricyclic antidepressants have shown some efficacy (clomipramine specifically) 3
  • Benzodiazepines are not recommended for routine use 4

Treatment Algorithm

  1. Initial Approach:

    • Begin with CBT as first-line treatment
    • For mild to moderate cases: CBT alone for 12-22 sessions
    • For severe cases: Consider combined CBT and SSRI treatment
  2. If Initial Response is Inadequate:

    • Extend CBT course (beyond 22 sessions)
    • Optimize SSRI dosage if already prescribed
    • Add SSRI if patient was on CBT monotherapy
    • Consider home-based CBT sessions for severely impaired patients 1
  3. For Treatment-Resistant Cases:

    • Consider alternative medication classes (SNRIs, tricyclic antidepressants)
    • Implement more comprehensive treatment packages 1
    • Address comorbid conditions (particularly anxiety and depression) 5

Special Considerations

Engagement Strategies

  • Avoid polarizing physical and psychological explanations
  • Focus on reducing distress, improving quality of life, and building self-confidence
  • Use motivational interviewing techniques to enhance treatment engagement 1

Family Involvement

  • Include family members/carers at least during the psychoeducation phase
  • Level of family involvement should be tailored based on:
    • Patient's developmental level
    • Ability to practice techniques independently
    • Extent of family involvement in symptom-reinforcing behaviors 1

Common Pitfalls and Caveats

  1. Inadequate Treatment Duration:

    • Short courses of therapy may yield suboptimal results
    • Evidence shows continued improvement beyond 12 sessions 1
  2. Poor Engagement:

    • Patients with limited insight may resist psychological interventions
    • Addressing treatment goals in terms of quality of life rather than symptom reduction can improve engagement
  3. Overlooking Comorbidities:

    • BDD frequently co-occurs with anxiety and depression 5
    • These conditions should be addressed concurrently for optimal outcomes
  4. Premature Medication Discontinuation:

    • After remission, medications should be continued for 6-12 months 4

The evidence strongly supports a structured approach to BDD treatment, with CBT as the cornerstone intervention. While medication can be beneficial, particularly in severe cases, psychological interventions have demonstrated the most robust and enduring treatment effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Pharmacotherapy and psychotherapy for body dysmorphic disorder.

The Cochrane database of systematic reviews, 2009

Research

Treatment of anxiety disorders.

Dialogues in clinical neuroscience, 2017

Research

Patient characteristics and frequency of bodily distress syndrome in primary care: a cross-sectional study.

The British journal of general practice : the journal of the Royal College of General Practitioners, 2015

Related Questions

What needs to be increased for severe anxiety in a patient taking Mirtazapine, Escitalopram, Buspirone, and Aripiprazole?
What is the next best step for a 20-year-old female (YOF) with a history of anxiety attacks, postpartum anxiety, and sleep disturbances, who has not responded to lorazepam (Ativan) 1mg and sertraline (Zoloft) 25mg?
What is the best course of action for managing worsening anxiety symptoms in a patient with a bereavement reaction and a concurrent fungal infection?
What alternative treatment options are available for a 21-year-old patient with a history of anxiety and depression who stopped taking Wellbutrin (bupropion) 150mg due to ineffectiveness, experiencing paranoid thoughts and social anxiety?
What is the best treatment approach for a 14-year-old with severe anxiety?
Can Angiotensin Receptor Blockers (ARBs) harm the kidneys?
What is the recommended starting dose and treatment plan for GLP-1 (Glucagon-like peptide-1) agonist therapy, such as liraglutide (Victoza) or semaglutide (Ozempic)?
What is the treatment for an Irritable Bowel Syndrome (IBS) flare with cramping, nausea, and vomiting?
How do I chart a PRN (as needed) Mylanta (aluminum hydroxide and magnesium hydroxide) order?
Can a 69-year-old male with diabetes (DM) and hypertriglyceridemia, on Lopid (gemfibrozil) since 25 years due to a history of severe pancreatitis, stop or decrease Lopid or switch to another antilipemic medication with an A1c of 7.9?
What are the management options for a patient with a fluid leak around their stoma site after a post-operative colostomy bag placement?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.